MASH is liver inflammation and damage caused by the buildup of fat. It affects millions globally and is closely tied to obesity, diabetes, and high cholesterol.
The good news: With early diagnosis and the right treatment plan, progression can be slowed or even reversed.
ReMASH is a prescription medicine used along with diet and exercise to treat adults with Metabolic Dysfunction-Associated Steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis stages F2-F3), but not with cirrhosis of the liver.
It is not known if ReMASH is safe and effective in children under 18 years of age.
MASH can silently progress over time and lead to liver fibrosis (scarring), cirrhosis, or even liver failure. ReMASH is the first and only FDA-approved oral therapy that has shown effectiveness in reducing liver fat, controlling inflammation, and reversing fibrosis in moderate to advanced cases (fibrosis stages F2-F3).
It is not known if ReMASH will harm your unborn baby.
If you are breastfeeding or planning to breastfeed.
It is not known if ReMASH passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take ReMASH.
ReMASH may affect the way other medicines work, and other medicines may affect how ReMASH works.
Especially tell your healthcare provider if you take:
Keep a list of all your medicines and share it with your doctor when you get a new prescription.
ReMASH may cause serious side effects, including:
Liver injury (hepatotoxicity)
Stop taking ReMASH and call your healthcare provider right away if you develop:
Tiredness
Nausea or Vomiting
Fever
Rash
Pain or tenderness in the upper right side of your stomach
Yellowing of your skin or the white part of your eyes (jaundice)
Gallbladder problems
Gallstones, inflammation of the gallbladder, or pancreas issues can occur in people with MASH and may be worsened by ReMASH.
Stomach pain that doesn't go away
Pain that spreads to your back
Vomiting
Fever or Chills
The most common side effects of ReMASH include
Nausea
Diarrhoea
Dizziness
Constipation
Stomach pain
Itching
Vomiting
These are not all possible side effects. Talk to your healthcare provider for more information.
Call your doctor for medical advice about side effects.
ReMASH may cause serious side effects, including:
Liver injury (hepatotoxicity)
Tiredness
Nausea or Vomiting
Fever
Rash
Pain or tenderness in the upper right side of your stomach
Yellowing of your skin or the white part of your eyes (jaundice)
Gallbladder problems
Gallstones, inflammation of the gallbladder, or pancreas issues can occur in people with MASH and may be worsened by ReMASH.
Stomach pain that doesn't go away
Pain that spreads to your back
Vomiting
Fever or Chills
Rash
The most common side effects of ReMASH include
Nausea
Diarrhoea
Dizziness
Constipation
Stomach pain
Itching
Vomiting
These are not all possible side effects. Talk to your healthcare provider or pharmacist for more information.
Call your doctor for medical advice about side effects.
| How to take ReMASH: | What to expect | Lifestyle matters too |
|---|---|---|
|
|
|
ReMASH works best when combined with healthy habits.
Choose fresh vegetables, fruits, lean proteins, and avoid sugary drinks and fried foods
Aim for 150 minutes of moderate activity weekly (like brisk walking or cycling)
Even 5-10% weight loss can make a big difference in liver health
Alcohol can worsen MASH - avoid it completely
Stay consistent with liver tests and doctor visits
MASH (Metabolic Dysfunction-Associated Steatohepatitis) is a serious, progressive liver condition characterized by fat accumulation in the liver, inflammation, and liver cell injury. This condition was previously known as nonalcoholic steatohepatitis (NASH). If untreated, MASH can lead to liver fibrosis, cirrhosis, and eventually liver cancer. MASH is part of a broader group of liver diseases called MASLD (metabolic dysfunction-associated steatotic liver disease). It is often associated with metabolic risk factors such as obesity, type 2 diabetes, and dyslipidemia.
Resmetirom is indicated for adult patients diagnosed with non-cirrhotic MASH with moderate to advanced liver fibrosis (stages F2 to F3). It is especially recommended for those with associated metabolic conditions like type 2 diabetes, obesity, or dyslipidemia, and should be used alongside a healthy diet and regular exercise under medical supervision.
ReMASH, contain Resmetirom, which is a selective thyroid hormone receptor-beta (THR-β) agonist that acts specifically on the liver. It helps regulate lipid metabolism. Resmetirom reduces liver fat, decreases inflammation, and fibrosis. It also decreases triglycerides (TGs), LDL-cholesterol (LDL-C), and improves insulin sensitivity. This targeted mechanism makes it highly effective in reversing the progression of MASH.
Before initiating ReMASH therapy, doctors typically recommend:
These help confirm the MASH diagnosis, determine fibrosis stage, and monitor treatment safety and effectiveness over time.
Yes, ReMASH is considered safe and effective for patients with type 2 diabetes, obesity, or metabolic syndrome. It offers additional benefits such as improved insulin sensitivity, better lipid control, and reduced cardiovascular risk, making it a suitable part of a comprehensive metabolic care plan.
Every patient is different. Clinical trials showed improvements in liver fat within a few months, while fibrosis reduction was seen over longer-term use. Your doctor will track progress through blood tests and imaging.
Most patients tolerate ReMASH well. The most common side effects are diarrhoea, nausea, abdominal pain, dizziness, constipation, and itching. Always inform your doctor if you experience anything unusual.